Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-18 9:44 pm Purchase | 13D | Cartesian Therapeutics Inc. RNAC | SPRINGER TIMOTHY A | 9,481,816 37.100% | 434,128 (+4.80%) | View |
2024-10-15 4:30 pm Purchase | 13D | Cartesian Therapeutics Inc. RNAC | Kalayoglu Murat | 5,058,026 19.900% | 1,519,640 (+42.95%) | View |
2024-10-04 6:08 pm Purchase | 13D | Cartesian Therapeutics Inc. RNAC | SPRINGER TIMOTHY A | 9,047,688 37.600% | 205,932 (+2.33%) | View |
2024-09-27 4:20 pm Purchase | 13D | Cartesian Therapeutics Inc. RNAC | SPRINGER TIMOTHY A | 8,841,756 36.700% | 8,650 (+0.10%) | View |
2024-08-12 09:40 am Purchase | 13G | Cartesian Therapeutics Inc. RNAC | FMR LLC | 2,722,656 12.734% | 2,024,768 (+290.13%) | View |
2024-07-12 6:12 pm Sale | 13G | Cartesian Therapeutics Inc. RNAC | Artal International S.C.A. | 594,940 2.800% | -9,860,909 (-94.31%) | View |
2024-07-05 4:15 pm Purchase | 13D | Cartesian Therapeutics Inc. RNAC | SPRINGER TIMOTHY A | 8,833,106 36.300% | 8,833,106 (New Position) | View |
2024-05-10 10:03 am Purchase | 13G | Cartesian Therapeutics Inc. RNAC | FMR LLC | 697,888 3.925% | 697,888 (New Position) | View |
2024-04-12 4:24 pm Sale | 13D | Cartesian Therapeutics Inc. RNAC | SPRINGER TIMOTHY A | 6,473,184 36.400% | -187,716,129 (-96.67%) | View |
2024-04-10 4:29 pm Sale | 13D | Cartesian Therapeutics Inc. RNAC | Kalayoglu Murat | 3,538,386 19.900% | -35,806,077 (-91.01%) | View |
2024-04-10 4:25 pm Sale | 13D | Cartesian Therapeutics Inc. RNAC | Singer Michael | 769,744 4.300% | -25,291,183 (-97.05%) | View |
2024-03-28 5:27 pm Purchase | 13D | Cartesian Therapeutics Inc. RNAC | SPRINGER TIMOTHY A | 194,189,313 27.900% | 1,248,649 (+0.65%) | View |
2024-03-11 08:19 am Purchase | 13G | Cartesian Therapeutics Inc. RNAC | FMR LLC | 16,869,200 10.417% | 3,612,826 (+27.25%) | View |
2024-02-14 12:38 pm Sale | 13G | Cartesian Therapeutics Inc. RNAC | MANGROVE PARTNERS IM LLC | 4,127,258 2.590% | -5,260,419 (-56.04%) | View |
2024-02-09 5:13 pm Purchase | 13G | Cartesian Therapeutics Inc. RNAC | Artal International S.C.A. | 10,455,849 6.400% | 248,859 (+2.44%) | View |
2024-02-09 08:50 am Purchase | 13G | Cartesian Therapeutics Inc. RNAC | FMR LLC | 13,256,374 8.186% | 13,256,374 (New Position) | View |
2023-11-22 4:39 pm Purchase | 13D | Cartesian Therapeutics Inc. RNAC | Singer Michael | 26,060,927 13.900% | 26,060,927 (New Position) | View |
2023-11-22 4:38 pm Purchase | 13D | Cartesian Therapeutics Inc. RNAC | Kalayoglu Murat | 39,344,463 19.900% | 39,344,463 (New Position) | View |
2023-11-17 08:15 am Purchase | 13D | Cartesian Therapeutics Inc. RNAC | SPRINGER TIMOTHY A | 192,940,664 27.700% | 148,584,078 (+334.98%) | View |
2023-09-22 7:31 pm Purchase | 13D | Cartesian Therapeutics Inc. RNAC | SPRINGER TIMOTHY A | 44,356,586 28.900% | 11,693,670 (+35.80%) | View |